close Icon

Improved colorimetric assay for detecting influenza B virus neutralizing antibody responses to vaccination and infection.

Tannock GA, Paul JA, Herd R, Barry RD, Reid AL, Hensley MJ, Gillett RS, Gillett SM, Lawrance P, Henry RL

VIEW FULL ARTICLE
  • Journal Journal of clinical microbiology

  • Published 22 Jun 1989

  • Volume 27

  • ISSUE 3

  • Pagination 524-8

  • DOI 10.1128/jcm.27.3.524-528.1989

Abstract

An automated neutralization test for influenza B virus is described in which antibody titers are determined according to the release of neutral red from infected or uninfected cells of the Madin-Darby canine kidney line. Endpoints are determined in a standard enzyme-linked immunosorbent assay reader. The test requires no expensive immunologic reagents and was used to evaluate responses to both vaccination and natural infection against influenza B virus. Overall responses to vaccination were comparable with those obtained by hemagglutination inhibition, using Tween-ether-split influenza B/Ann Arbor/1/86 virus as the antigen (the HI-TE test). The sensitivities of neutralization responses compared with those obtained by the HI-TE test for two vaccines were 88 and 89%; the specificities were lower at 61 and 60%, respectively. Responses to vaccination, measured by hemagglutination inhibition, were significantly higher with split virus compared with whole virus. However, seroconversion by both the HI-TE and neutralization tests was observed in 5 of 10 individuals from whom virus was detected by either culture of nasal or throat washings or the presence of antigen from immunofluorescence in cells from nasal washings.